Identification of JTP-70902, a p15INK4b-inductive compound, as a novel MEK1/2 inhibitor-Reference-Cited by-同舟云学术

Identification of JTP-70902, a p15INK4b-inductive compound, as a novel MEK1/2 inhibitor

Published:2007-11 Issue:11 Volume:98 Page:1809-1816
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Yamaguchi Takayuki,Yoshida Takayuki,Kurachi Reina,Kakegawa Junya,Hori Yoshikazu,Nanayama Toyomichi,Hayakawa Kazuhide,Abe Hiroyuki,Takagi Koichi,Matsuzaki Youichirou,Koyama Makoto,Yogosawa Shingo,Sowa Yoshihiro,Yamori Takao,Tajima Nobuyuki,Sakai Toshiyuki

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2007.00604.x/fullpdf

Reference45 articles.

1. Announcements

2. Physical interaction of the retinoblastoma protein with human D cyclins

3. The regulation of E2F by pRB-family proteins

4. Targeting the mitogen-activated protein kinase cascade to treat cancer

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FDA-approved small molecule kinase inhibitors for cancer treatment (2001–2015): Medical indication, structural optimization, and binding mode Part I;Bioorganic & Medicinal Chemistry;2024-09

2. Trametinib activates endogenous neurogenesis and recovers neuropathology in a model of Alzheimer’s disease;Experimental & Molecular Medicine;2023-10-02

3. MEK Inhibitors;Molecules Engineered Against Oncogenic Proteins and Cancer;2023-09-08

4. Research progress in small-molecule modulators of protein-protein interactions;Chinese Science Bulletin;2023-05-11

5. Predictive biomarkers for response to trametinib in non-small cell lung cancer;Tumor Biology;2022-12-09